AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Primary Health Properties PLC

Remuneration Information Jul 27, 2023

4780_dirs_2023-07-27_d96b932a-07f7-41c7-8ce6-482dc098b719.html

Remuneration Information

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 4423H

Primary Health Properties PLC

27 July 2023

Primary Health Properties PLC

PDMR dealing

On 25 July 2023, the Remuneration Committee of Primary Health Properties PLC (the "Company" or "PHP") made the following award of nil-cost options under the Company's 2021 Long-term Incentive Plan ("LTIP") to a Person Discharging Managerial Responsibilities ("PDMR"):

PDMR Number of shares under option
Toby Newman 88,737

The number of nil-cost options was calculated by reference to a price of £1.08, being the average of the closing middle market quotations for the Company's ordinary shares on 22 February 2023, 23 February 2023 and 24 February 2023 (to align with grants previously made under the LTIP this year). 

The nil-cost options will normally vest on the third anniversary of grant (treated as 27 February 2023 to align with grants previously made under the LTIP this year), subject to the attainment of performance conditions.  The Remuneration Committee has the discretion to adjust the awards downwards at vesting for malus reasons.  Details of the operation of the LTIP are set out in the Company's 2021 Report and Accounts.

Details of the transactions referenced above are included below in accordance with Article 19 of the retained EU law version of the Market Abuse Regulation (Regulation 596/2014).

1 Details of Person Discharging Managerial Responsibility/person closely associated with them ("PCA")
(a) Name Toby Newman
2 Reason for the notification
(a) Position/status Company Secretary & Chief Legal Officer
(b) Initial notification/ amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
(a) Name of Entity Primary Health Properties PLC
(b) Legal Entity Identifier 213800Y5CJHXOATK7X11
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date: and (iv) each place where transactions have been conducted
(a) Description of the financial instrument Ordinary shares of 12.5p

ISIN: GB00BYRJ5J14
(b) Nature of the transaction Award of nil-cost options over the Company's ordinary shares
(c) Aggregated information

Price(s) and volume(s)
Price(s) Volume(s)
Nil cost 88,737
(d) Aggregated volume price Single transaction: N/A
(e) Date of transaction 26 July 2023
(f) Place of transaction n/a

More information on Primary Health Properties PLC can be found on www.phpgroup.co.uk

Further details:

Harry Hyman

Chief Executive Officer

Tel: +44 (0) 7973 344 768
Richard Howell

Chief Financial Officer

Tel: +44 (0) 776 6072 272
David Rydell / Jamie Hooper / Hannah Ratcliff / Verity Parker  (Buchanan Communications)

Tel: +44 (0) 20 7466 5066

Legal Entity Identifier: 213800Y5CJHXOATK7X11

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHBBGDRXDDDGXR

Talk to a Data Expert

Have a question? We'll get back to you promptly.